ATE107362T1 - Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns. - Google Patents

Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.

Info

Publication number
ATE107362T1
ATE107362T1 AT87108709T AT87108709T ATE107362T1 AT E107362 T1 ATE107362 T1 AT E107362T1 AT 87108709 T AT87108709 T AT 87108709T AT 87108709 T AT87108709 T AT 87108709T AT E107362 T1 ATE107362 T1 AT E107362T1
Authority
AT
Austria
Prior art keywords
human tnf
mutants
tnf polypeptide
dna encoding
polypeptide mutant
Prior art date
Application number
AT87108709T
Other languages
English (en)
Inventor
Junichi Yamagishi
Hitoshi Kawashima
Ryuji Furuta
Hirotada Kotani
Katuhisa Nakata
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of ATE107362T1 publication Critical patent/ATE107362T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87108709T 1986-06-20 1987-06-16 Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns. ATE107362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14557586 1986-06-20

Publications (1)

Publication Number Publication Date
ATE107362T1 true ATE107362T1 (de) 1994-07-15

Family

ID=15388278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108709T ATE107362T1 (de) 1986-06-20 1987-06-16 Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.

Country Status (10)

Country Link
US (1) US4990455A (de)
EP (1) EP0251037B1 (de)
KR (1) KR880000471A (de)
AT (1) ATE107362T1 (de)
AU (1) AU592196B2 (de)
DE (1) DE3750056T2 (de)
DK (1) DK312387A (de)
HU (1) HU210118B (de)
PH (1) PH26714A (de)
SU (1) SU1762761A3 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247906B1 (de) * 1986-02-04 1994-12-28 Mizuno, Den'Ichi Für Antitumor-Polypeptide kodierende DNS, die Polypeptide und diese Polypeptide enthaltenden Antitumor-Wirkstoffe
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
DE3922089A1 (de) * 1989-05-09 1990-12-13 Basf Ag Neue proteine und ihre herstellung
US6262239B1 (en) * 1989-05-18 2001-07-17 Yeda Research And Development Co., Ltd. TNF receptor-specific antibodies
US6232446B1 (en) * 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
JP3203599B2 (ja) * 1989-10-24 2001-08-27 カイロン コーポレイション 感染性タンパク質デリバリーシステム
US5519119A (en) * 1990-09-21 1996-05-21 Ishihara Sangyo Kaisha Ltd. Muteins of TNF pharmaceutical compositions and a method of making
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
CA2055168A1 (en) * 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
US6184344B1 (en) * 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
CN1178955C (zh) 1997-04-15 2004-12-08 法默卡有限公司 经修饰的TNFα分子和编码该TNFα分子的DNA以及含有该TNFα分子和该DNA的疫苗
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7244823B2 (en) 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7687461B2 (en) 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
KR100475403B1 (ko) * 2002-05-28 2005-03-15 재단법인서울대학교산학협력재단 반도체 배선용 구리 박막 형성방법
US7285269B2 (en) * 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
EP3936137A1 (de) 2013-02-07 2022-01-12 The General Hospital Corporation Verfahren zur expansion oder abreicherung von t-regulatorischen zellen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723249A (en) * 1970-02-21 1973-03-27 Ajinomoto Kk Method of producing l-arginine by microorganism
JPS6066989A (ja) * 1983-09-24 1985-04-17 Kyowa Hakko Kogyo Co Ltd Ｌ−アルギニンの製造法
EP0155549B1 (de) * 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. DNS den menschlichen Tumornekrosisfaktor kodierend und das menschliche Tumornekronisfaktor-Polypeptid
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
AU589919B2 (en) * 1984-10-15 1989-10-26 Cetus Corp Human tumor necrosis factor
EP0205038A1 (de) * 1985-05-29 1986-12-17 Suntory Limited Polypeptid, Verfahren zu dessen Herstellung, Mikroorganismus und pharmazeutische Verwendung

Also Published As

Publication number Publication date
EP0251037B1 (de) 1994-06-15
DK312387D0 (da) 1987-06-19
HUT46065A (en) 1988-09-28
DK312387A (da) 1987-12-21
US4990455A (en) 1991-02-05
DE3750056D1 (de) 1994-07-21
AU592196B2 (en) 1990-01-04
EP0251037A2 (de) 1988-01-07
HU210118B (en) 1995-02-28
DE3750056T2 (de) 1995-04-06
EP0251037A3 (en) 1988-12-07
PH26714A (en) 1992-09-15
SU1762761A3 (ru) 1992-09-15
AU7450887A (en) 1988-01-07
KR880000471A (ko) 1988-03-26

Similar Documents

Publication Publication Date Title
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
SG76988G (en) Human immune interferon and its production by recombinant dna technology
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
IL80678A0 (en) Mammalian interleukin-4
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
AU6661490A (en) Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization
SE8505920D0 (sv) New protein and its use
ZA856907B (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl)amino)-3-furancarboxylic acids and derivatives thereof
KR970009340B1 (en) Mutant acidic fibroblast growth factor
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
KR860007376A (ko) 인터로이킨-2의 제조방법
DE69306273D1 (de) Mitogen für die glatte Muskulatur und dessen kodierende DNS
NO174474C (no) FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee